Phibro Animal Health
(NASDAQ) PAHC
Phibro Animal Health Financials at a Glance
Market Cap
$1.32B
Revenue (TTM)
$1.50B
Net Income (TTM)
$95.23M
EPS (TTM)
$2.33
P/E Ratio
13.93
Dividend
$0.48
Beta (Volatility)
0.91 (Low)
Dividend
$0.48
Beta (Volatility)
0.91 (Low)
Price
$32.51
Volume
11,027
Open
$33.63
Price
$32.51
Volume
11,027
Open
$33.63
Previous Close
$32.51
Daily Range
$32.51 - $33.91
52-Week Range
$22.85 - $60.08
Estimated Earnings Date
Aug 26, 2026
Dividend
$0.48
Beta (Volatility)
0.91 (Low)
Price
$32.51
Volume
11,027
Open
$33.63
Previous Close
$32.51
Daily Range
$32.51 - $33.91
52-Week Range
$22.85 - $60.08
Estimated Earnings Date
Aug 26, 2026
PAHC News
PAHC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Phibro Animal Health
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,475
CEO
Jack C. Bendheim
Website
www.pahc.comHeadquarters
Teaneck, NJ 07666-6712, US
PAHC Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
12%
Net Income Margin
6%
Return on Equity
30%
Return on Capital
16%
Return on Assets
7%
Earnings Yield
7.18%
Dividend Yield
1.48%
Payout Ratio
20.43%
Stock Overview
Market Cap
$1.32B
Shares Outstanding
40.56M
Volume
11.03K
Avg. Volume
367.68K
Financials (TTM)
Gross Profit
$399.94M
Operating Income
$110.47M
EBITDA
$146.85M
Operating Cash Flow
$80.12M
Capital Expenditure
-$38.29M
Free Cash Flow
$41.83M
Cash & ST Invst.
$77.04M
Total Debt
$761.55M
Phibro Animal Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$383.54M
+10.3%
Gross Profit
$124.87M
+19.4%
Gross Margin
32.56%
N/A
Market Cap
$1.32B
N/A
Market Cap/Employee
$678.10K
N/A
Employees
1,940
N/A
Net Income
$24.02M
+15.1%
EBITDA
$60.42M
+17.6%
Quarterly Fundamentals
Net Cash
-$709.99M
-1.5%
Accounts Receivable
$221.55M
+12.2%
Inventory
$539.70M
+20.4%
Long Term Debt
$755.19M
+1.4%
Short Term Debt
$32.25M
+27.8%
Return on Assets
6.59%
N/A
Return on Invested Capital
15.82%
N/A
Free Cash Flow
$890.00K
-97.5%
Operating Cash Flow
$16.21M
-62.4%